OPPENHEIMER HOLDINGS INC (OPY) Balance Sheet
As of 2026-06-30 (10-Q), OPPENHEIMER HOLDINGS INC (OPY) reported total assets of $4.2B, total liabilities of $3.2B and shareholders' equity of $983.4M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $38.5M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OPYOPPENHEIMER HOLDINGS INCFollow OPY — free
—
Price chart with a free account
- Market cap
- 1.1B
- P/E TTM
- —
- Dividend yield
- 1.7%
- 52-week
- —
- Next earnings
- 23 Oct, in -1 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.07 | 0.14 | 0.10 | 0.06 | 0.06 | 0.06 | 0.05 | 0.09 | 0.08 | 0.04 | 0.21 | 0.11 | 0.03 | 0.03 | 0.04 | 0.04 | |
| Total assets | 3.53 | 2.68 | 2.95 | 2.79 | 2.70 | 2.24 | 2.44 | 2.24 | 2.46 | 2.71 | 3.04 | 2.71 | 2.87 | 3.38 | 3.72 | 4.23 | |
| Long-term debt | 0.20 | 0.20 | 0.20 | 0.15 | 0.15 | 0.15 | 0.20 | 0.20 | 0.15 | 0.12 | 0.12 | 0.11 | 0.11 | 0.00 | — | — | |
| Total liabilities | 3.01 | 2.17 | 2.42 | 2.25 | 2.17 | 1.72 | 1.91 | 1.69 | 1.87 | 2.03 | 2.09 | 1.89 | 2.09 | 2.53 | 2.73 | 3.23 | |
| Shareholders' equity | 0.51 | 0.50 | 0.52 | 0.53 | 0.52 | 0.51 | 0.52 | 0.55 | 0.59 | 0.69 | 0.82 | 0.79 | 0.79 | 0.85 | 0.98 | 0.98 |
USD billions · SEC XBRL
OPPENHEIMER HOLDINGS INC — questions
- How much cash does OPPENHEIMER HOLDINGS INC have?
- $38.5M in cash and cash equivalents as of 2026-06-30.
- What are OPPENHEIMER HOLDINGS INC's total assets?
- $4.2B as of 2026-06-30.
- What is OPPENHEIMER HOLDINGS INC's shareholders' equity?
- $983.4M as of 2026-06-30.
Every figure on this page comes from OPPENHEIMER HOLDINGS INC's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.